We offer vaccination to prevent shingles with the highly effective new non-live shingles vaccine; early booking is advised as stock is limited; see below for details (you pay £220 when you come in for each dose – £440 inclusive for the full course i.e. both doses).
We also offer vaccinations with the live shingles vaccine (£160 inclusive – paid at your appointment).
Even the healthiest lifestyle cannot stop your immune system from declining as you age. If you want protection against shingles, it takes more than exercise—it takes the new non-live shingles vaccine.
- Vaccinations are done at our clinic in London OR at your home.
- We take all precautions required to protect you from coronavirus (COVID-19). All of our team have received the COVID-19 vaccination.
- To book an appointment in our clinic, please call us on 020 7435 7075
- We are unable to book appointments for our vaccination clinic via email
- The vaccination home visit fee is approx. £80 per visit for London zone 1 to 2 and approx. £10.00 per mile from NW3 for other areas. To arrange a home visit, please email the service required, your post code and mobile number to firstname.lastname@example.org
Shingles Vaccination Service
We offer vaccination against shingles with the highly effective new non-live shingles vaccine Shingrix manufactured by GSK which is licensed in the UK but stock is very scarce.
- Shingrix is a non-live vaccine used in adults aged 50 years and over to protect against shingles (herpes zoster) and post-herpetic neuralgia (long-lasting nerve pain following shingles)
- It can also be used from the age of 18 years and over in adults who are at increased risk of shingles
For more information about the NEW shingles vaccine, visit the following official websites:
The UK Package leaflet: Information for the user:
A US resource (CDC) info on Shingrix:
The cost is £440 for the full course of 2 vaccines given 2 months apart (there is not any other fees).
The stock / appointment is going to be allocated on first come first serve basis.
- To book an appointment, please call 020 7435 7075. We cannot arrange appointments via email
- We are based at 35 South End Road, London, NW3 2PY (right opposite the Hampstead Heath Overground Station)
- Because of cold chain requirements and issues related to prescribing responsibility, we cannot send out the vaccine to you or supply the vaccine to you to be given elsewhere
Shingles is a painful and unpredictable disease. Shingles is debilitating, very common and it can be associated with serious complications. Vaccination is the best way to help protect yourself against shingles (from www.cdc.gov – a US resource).
Vaccination against shingles
Cochrane Reviews which provide the most reliable health evidence states, “There is a clear benefit for vaccination of older adults with both attenuated live zoster vaccine (LZV) and recombinant zoster vaccine (RZV) against herpes zoster [shingles] with no major safety or tolerance concerns. Herpes zoster is more frequent amongst older adults, and its main clinical feature is pain, therefore preventing herpes zoster is desirable.”
What’s the difference between the old live shingles vaccine and new non-live shingles vaccine?*
The live shingles vaccine (i.e. the shingles vaccine currently used by the NHS) is given as a single dose and can reduce the risk of shingles by 51%, post-herpetic neuralgia by 67%, and the overall burden of illness by 61%. The live shingles vaccine becomes less effective with increasing age, and efficacy wanes completely approximately 10 years after vaccination.
The new non-live shingles vaccine contains a small part of the varicella zoster virus plus adjuvant. An adjuvant is a substance that enhances the response of the body against a stimulus (bacteria, viruses, and substances that appear foreign and harmful) to defend itself. This vaccine requires two doses 2 to 6 months apart, and has a substantially higher efficacy than the live vaccine, reducing risk of shingles by 97%. Early studies suggest a single dose does not produce a robust immune response, so attendance for both doses is important.
Unlike live shingles vaccine, the efficacy of new non-live shingles vaccine is high even for patients over 70.
With the non-live shingles vaccine, in adults vaccinated at ≥60 years of age, immunity persist, up to the latest assessment, 10 years after initial vaccination. Statistical modeling predicts persistence immune responses for ≥20 years after initial vaccination (for more information see here).
The new non-live shingles vaccine might carry a greater risk of side effects (non-serious) at injection sites such as pain, redness and swelling. Side effects of the new non-live shingles vaccine are more frequent after the second dose than after the first.
The new non-live shingles vaccine is safe and effective in patients previously vaccinated with the live shingles vaccine.
*Reference: Le Phuc, Rothberg Michael. Herpes zoster infection BMJ 2019; 364 :k5095
“Five years later, I still take medicines for pain. My shingles rash quickly developed into open, oozing sores that in only a few days required me to be hospitalised. I could not eat, sleep, or perform even the most minor tasks. It was totally debilitating. The pain still limits my activity levels to this day.” – A 63 year old harpist who was unable to continue playing due to shingles.
The pain from shingles has been compared to childbirth or passing a kidney stone. It can last for months or years after the rash goes away. Shingles vaccine can help prevent shingles and the complications from the disease.
Can the new non-live shingles vaccine be given to immunocompromised individuals?
The new non-live shingles vaccine can be given to people who are immunocompromised. You can still get the new non-live shingles vaccine if you are taking immunosuppressive medication, anticipating immunosuppression, or have recovered from an immunocompromising illness. People who are immunosuppressed, as occurs with leukemia, lymphoma, and human immunodeficiency virus (HIV) infection, and people who receive immunosuppressive drugs, such as steroids and cancer chemotherapy are at greater risk of shingles. There is evidence that the non-live shingles vaccine is safe and effective in people with blood cancers, stem cell transplantation and those immunocompromised after renal transplantation (see the relevant studies here respectively: 1 – 2 – 3).
The live shingles vaccine (the old shingles vaccine; one available on the NHS for over 70s) should not be given to someone who is immunocompromised.
Can someone who has had shingles be vaccinated with the new non-live shingles vaccine?
Yes, if you had shingles in the past, you can get Shingrix to help prevent future occurrences of the disease. There is no specific length of time that you need to wait after having shingles before you can receive Shingrix, but generally you should make sure the shingles rash has gone away before getting vaccinated.
Can the new non-live shingles vaccine be given to people who have already received the old live shingles vaccine? If so what interval should separate them?
Yes, people who previously received the old shingles vaccine, can receive two doses of the new shingles vaccine. The first dose of the new shingles vaccine should be given at least 2 months after the old version given.
Is there an upper age limit for receipt of new non-live shingles vaccine?
There is no upper age limit for either shingles vaccine.
Do you need to have the new non-live shingles vaccine every year?
No, it is a one-off course of two injections.
Can the new non-live shingles vaccine be given at the same time as other vaccines?
Yes, the vaccine can safely be given at the same time or any time before or after other vaccines including the seasonal flu vaccine and the pneumonia vaccine.
Administration of COVID-19 vaccines should ideally be separated from any other vaccine by an interval of at least 7 days to avoid incorrect attribution of potential adverse events.
How safe is the new non-live shingles vaccine?
There is good evidence showing that the new shingles vaccine is safe. It is already been used in three countries, and no safety concerns have been raised. The vaccine has few side effects.
Review of the initial data from the post-marketing safety surveillance has shown that the safety profile of this vaccine is consistent with that previously observed in pre-licensure clinical trials. Other studies are ongoing and planned, to continue generating real-world safety data and further characterise the new non-live shingles vaccine (see the relevant reference here)
Will there be any side effects from the new non-live shingles vaccine?
- Most people had a sore arm.
- Many people had redness and swelling where they got the shot (wider than 4 inches for some people).
- Many felt tired, had muscle pain, a headache, shivering, fever, stomach pain, or nausea.
Side effects usually go away after 2 to 3 days. Remember that the pain from shingles can last a lifetime, and these side effects should only last a few days.
For the full list of side effects and restrictions with the new shingles vaccine, see the package leaflet ( page 25 to 28).
The first post-marketing safety data is reassuring (published by CDC in Feb 2019); serious adverse events were rare, and no unexpected patterns were detected.
How is the new non-live shingles vaccine given?
It is given as an injection into the upper arm.
Do I need the new non-live shingles vaccine if I’ve never had chickenpox?
Yes, the chances are that you have had chickenpox at some point without knowing it. Some people have chickenpox without displaying any of the typical chickenpox symptoms like rash.
Is the new non-live shingles vaccine available on the NHS?
Yes, but it is only given to those who cannot have the live shingles vaccine because of a medical reason.
In addition to provision of shingles vaccination with the new non-live shingles for people 18 years of age and above, we provide vaccination with the live shingles vaccine privately for people 50 years of age and over: £160 – given as a single dose.
I am under 50 years of age, can I get vaccinated with the non-live shingles vaccine?
Yes, since Sep 2020, the non-live shingles vaccine has been approved to be given to adults 18 years of age or older at increased risk of shingles.
Efficacy of the live shingles vaccine (one available on the NHS). Reduction of shingles incidence compared with placebo (https://goo.gl/sjJEFR).
You may have already got a different shingles vaccine before. If you did, you can still get the new shingles vaccine.
The Shingles Support Society offers support to people with shingles & postherpetic neuralgia: 0845 123 2305 or https://shinglessupport.org.uk/
Benefits & side effects of the new shingles vaccine (from www.cdc.gov – a US resource).
The new non-live shingles vaccine is the only shingles vaccine to achieve ≥90% efficacy across all age groups studied (from GSK press release 23/03/18: https://goo.gl/T9XXjs).
I feel healthy; am I really at risk for shingles?
If you’re one of the 99% of adults over 50 years old who have had chickenpox, the virus that causes shingles is inside your body and can reactivate at any time. It is estimated that around 1 in 4 people will get shingles in their lifetime. No matter how healthy you feel, your immune system declines as you age, and that puts you at an increased risk for shingles.
How do you catch shingles?
Shingles is not caused by exposure to another person with shingles. People with shingles can only possibly cause a susceptible person to develop chickenpox, not shingles.
There is no evidence that shingles can be acquired from another individual who has chickenpox.
What is post-herpetic neuralgia (PHN)?
After the shingles blisters heal, pain can last for months or years and may be severe. This long-lasting nerve pain is called post-herpetic neuralgia or PHN.
Is shingles serious?
Yes, it can be. Not only can shingles be very painful and uncomfortable, some people are left with long-lasting pain called postherpetic neuralgia (PHN) for years after the initial rash has healed. Very occasionally, shingles can be fatal.
Shingles, in some cases, disseminate into the lungs, liver, gut, and brain, leading to pneumonia, hepatitis, encephalitis. Disseminated shingles is more likely to occur in those who are severely immunocompromised, with a case fatality rate reported to be between 5 and 15%, and most deaths being attributable to pneumonia.
Who is at an increased risk of shingles?
The incidence and the burden of shingles increases with age. The risk of shingles is also increased in individuals with certain conditions, including systemic lupus erythematosus, rheumatoid arthritis, diabetes and Wegener’s granulomatosis.
Cost of vaccinations against shingles with the NEW non-live vaccine: £440 for the full course – 2 doses required 2 months apart (i.e. there is no consultation fees).
Cost of vaccinations against shingles with the OLD live vaccine: £160 – 1 dose required (i.e. there is no consultation fees).
To book an in-clinic appointment call: 020 7435 7075
To arrange a home visit email your post code to: email@example.com
Our telephone line is open Mon – Fri 9:00 to 18:30 & Saturday: 9:00 to 17:30